Net Income (Loss) Attributable to Parent in USD of Accelerate Diagnostics, Inc from Q3 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Accelerate Diagnostics, Inc quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q3 2010 to Q4 2024.
  • Accelerate Diagnostics, Inc Net Income (Loss) Attributable to Parent for the quarter ending 31 Dec 2024 was -$9.59M, a 26.2% increase year-over-year.
  • Accelerate Diagnostics, Inc Net Income (Loss) Attributable to Parent for the twelve months ending 31 Dec 2024 was -$50M, a 18.8% increase year-over-year.
  • Accelerate Diagnostics, Inc annual Net Income (Loss) Attributable to Parent for 2024 was -$50M, a 18.8% increase from 2023.
  • Accelerate Diagnostics, Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$61.6M, a 1.4% increase from 2022.
  • Accelerate Diagnostics, Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$62.5M, a 19.6% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Accelerate Diagnostics, Inc Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$50M -$9.59M +$3.41M +26.2% 01 Oct 2024 31 Dec 2024 10-K 21 Mar 2025
Q3 2024 -$53.5M -$14.6M -$15.5M -1709% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 -$37.9M -$11.6M +$21.1M +64.6% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 -$59.1M -$14.2M +$2.57M +15.3% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2024
Q4 2023 -$61.6M -$13M +$1.61M +11% 01 Oct 2023 31 Dec 2023 10-K 21 Mar 2025
Q3 2023 -$63.2M $910K +$16.8M 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 -$80M -$32.7M -$14.2M -76.7% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$65.8M -$16.8M -$3.33M -24.7% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q4 2022 -$62.5M -$14.6M +$8.19M +35.9% 01 Oct 2022 31 Dec 2022 10-K 31 Mar 2023
Q3 2022 -$70.7M -$15.9M -$6.91M -76.9% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$63.8M -$18.5M +$3.15M +14.5% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 -$66.9M -$13.5M +$10.8M +44.4% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$77.7M -$22.8M -$3.89M -20.6% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 -$73.8M -$8.99M +$9.77M +52.1% 01 Jul 2021 30 Sep 2021 10-K 31 Mar 2023
Q2 2021 -$83.6M -$21.7M -$2.44M -12.7% 01 Apr 2021 30 Jun 2021 10-K 31 Mar 2023
Q1 2021 -$81.1M -$24.2M -$2.93M -13.8% 01 Jan 2021 31 Mar 2021 10-K 31 Mar 2023
Q4 2020 -$78.2M -$18.9M +$2.42M +11.4% 01 Oct 2020 31 Dec 2020 10-K 14 Mar 2022
Q3 2020 -$80.6M -$18.8M +$1.68M +8.21% 01 Jul 2020 30 Sep 2020 10-K 14 Mar 2022
Q2 2020 -$82.3M -$19.2M +$1.59M +7.62% 01 Apr 2020 30 Jun 2020 10-K 14 Mar 2022
Q1 2020 -$83.9M -$21.3M +$412K +1.9% 01 Jan 2020 31 Mar 2020 10-K 14 Mar 2022
Q4 2019 -$84.3M -$21.3M +$856K +3.86% 01 Oct 2019 31 Dec 2019 10-K 02 Mar 2021
Q3 2019 -$85.2M -$20.4M +$1.66M +7.53% 01 Jul 2019 30 Sep 2019 10-K 02 Mar 2021
Q2 2019 -$86.8M -$20.8M +$2.41M +10.4% 01 Apr 2019 30 Jun 2019 10-K 02 Mar 2021
Q1 2019 -$89.2M -$21.7M -$909K -4.37% 01 Jan 2019 31 Mar 2019 10-K 02 Mar 2021
Q4 2018 -$88.3M -$22.2M -$5.9M -36.2% 01 Oct 2018 31 Dec 2018 10-K 28 Feb 2020
Q3 2018 -$82.4M -$22.1M -$5.02M -29.4% 01 Jul 2018 30 Sep 2018 10-K 28 Feb 2020
Q2 2018 -$77.4M -$23.2M -$6.77M -41.1% 01 Apr 2018 30 Jun 2018 10-K 28 Feb 2020
Q1 2018 -$70.6M -$20.8M -$6.61M -46.6% 01 Jan 2018 31 Mar 2018 10-K 28 Feb 2020
Q4 2017 -$64M -$16.3M -$161K -1% 01 Oct 2017 31 Dec 2017 10-K 01 Mar 2019
Q3 2017 -$63.9M -$17.1M +$224K +1.3% 01 Jul 2017 30 Sep 2017 10-K 01 Mar 2019
Q2 2017 -$64.1M -$16.5M +$1.41M +7.89% 01 Apr 2017 30 Jun 2017 10-K 01 Mar 2019
Q1 2017 -$65.5M -$14.2M +$874K +5.8% 01 Jan 2017 31 Mar 2017 10-K 01 Mar 2019
Q4 2016 -$66.4M -$16.1M -$2.97M -22.6% 01 Oct 2016 31 Dec 2016 10-K 01 Mar 2018
Q3 2016 -$63.4M -$17.3M -$6.11M -54.6% 01 Jul 2016 30 Sep 2016 10-K 01 Mar 2018
Q2 2016 -$57.3M -$17.9M -$5.61M -45.8% 01 Apr 2016 30 Jun 2016 10-K 01 Mar 2018
Q1 2016 -$51.7M -$15.1M -$6.18M -69.4% 01 Jan 2016 31 Mar 2016 10-K 01 Mar 2018
Q4 2015 -$45.5M -$13.2M -$4.4M -50.2% 01 Oct 2015 31 Dec 2015 10-K 28 Feb 2017
Q3 2015 -$41.1M -$11.2M -$2.37M -26.9% 01 Jul 2015 30 Sep 2015 10-K 28 Feb 2017
Q2 2015 -$38.7M -$12.3M -$4.1M -50.3% 01 Apr 2015 30 Jun 2015 10-K 28 Feb 2017
Q1 2015 -$34.6M -$8.9M -$3.7M -71% 01 Jan 2015 31 Mar 2015 10-K 28 Feb 2017
Q4 2014 -$30.9M -$8.77M -$3.61M -69.9% 01 Oct 2014 31 Dec 2014 10-K 09 Mar 2016
Q3 2014 -$27.3M -$8.81M -$5.02M -132% 01 Jul 2014 30 Sep 2014 10-K 09 Mar 2016
Q2 2014 -$22.3M -$8.15M -$4.38M -116% 01 Apr 2014 30 Jun 2014 10-K 09 Mar 2016
Q1 2014 -$17.9M -$5.2M -$2.65M -104% 01 Jan 2014 31 Mar 2014 10-K 09 Mar 2016
Q4 2013 -$15.3M -$5.16M 01 Oct 2013 31 Dec 2013 10-K 26 Feb 2015
Q3 2013 -$3.8M +$39.3K +1.03% 01 Jul 2013 30 Sep 2013 10-K 26 Feb 2015
Q2 2013 -$3.78M -$2.65M -236% 01 Apr 2013 30 Jun 2013 10-K 26 Feb 2015
Q1 2013 -$2.55M -$2.25M -751% 01 Jan 2013 31 Mar 2013 10-K 26 Feb 2015
Q3 2012 -$5.58M -$3.84M -$3.41M -792% 01 Jul 2012 30 Sep 2012 10-Q 08 Nov 2013
Q2 2012 -$2.18M -$1.12M -$828K -280% 01 Apr 2012 30 Jun 2012 10-Q 09 Aug 2013
Q1 2012 -$1.35M -$300K -$176K -142% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013
Q4 2011 -$1.17M -$323K -$297K 01 Nov 2011 31 Jan 2012 10-Q 15 Mar 2012
Q3 2011 -$876K -$430K -$498K -740% 01 Aug 2011 31 Oct 2011 10-Q 14 Dec 2012
Q2 2011 -$379K -$296K 01 May 2011 31 Jul 2011 10-K 07 Mar 2014
Q1 2011 -$124K 01 Feb 2011 30 Apr 2011 10-Q/A 15 Jun 2012
Q4 2010 -$26.4K* 01 Nov 2010 31 Jan 2011 10-Q 15 Mar 2012
Q3 2010 $67.3K 01 Aug 2010 31 Oct 2010 10-Q 14 Dec 2011

Accelerate Diagnostics, Inc Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$50M +$11.6M +18.8% 01 Jan 2024 31 Dec 2024 10-K 21 Mar 2025
2023 -$61.6M +$875K +1.4% 01 Jan 2023 31 Dec 2023 10-K 21 Mar 2025
2022 -$62.5M +$15.2M +19.6% 01 Jan 2022 31 Dec 2022 10-K 29 Mar 2024
2021 -$77.7M +$506K +0.65% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2024
2020 -$78.2M +$6.1M +7.23% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2023
2019 -$84.3M +$4.02M +4.55% 01 Jan 2019 31 Dec 2019 10-K 14 Mar 2022
2018 -$88.3M -$24.3M -37.9% 01 Jan 2018 31 Dec 2018 10-K 02 Mar 2021
2017 -$64M +$2.35M +3.54% 01 Jan 2017 31 Dec 2017 10-K 28 Feb 2020
2016 -$66.4M -$20.9M -45.9% 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2019
2015 -$45.5M -$14.6M -47.1% 01 Jan 2015 31 Dec 2015 10-K 01 Mar 2018
2014 -$30.9M -$15.7M -102% 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017
2013 -$15.3M -$9.97M -188% 01 Jan 2013 31 Dec 2013 10-K 09 Mar 2016
2012 -$5.31M -$4.93M -1302% 01 Aug 2011 31 Jul 2012 10-K 26 Feb 2015
2011 -$379K 01 Aug 2010 31 Jul 2011 10-K 07 Mar 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.